Co-Treatment With Vactosertib, a Novel, Orally Bioavailable Activin Receptor-Like Kinase 5 Inhibitor, Suppresses Radiotherapy-Induced Epithelial-to-Mesenchymal Transition, Cancer Cell Stemness, and Lung Metastasis of Breast Cancer: ALK5 Inhibitor Suppressed Radiation Induced Metastasis. Radiol Oncol 2022, 56 (2), 185-197.